Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TAC01-CLDN18.2 |
Synonyms | |
Therapy Description |
TAC01-CLDN18.2 are T-lymphocytes engineered to express a T-cell antigen coupler (TAC) targeting CLDN18.2, which potentially inhibit growth of CLDN18.2-expressing tumors (Journal for ImmunoTherapy of Cancer 2022;10). |